Related references
Note: Only part of the references are listed.Delayed Fragmentation and Optimized Isolation Width Settings for Improvement of Protein Identification and Accuracy of Isobaric Mass Tag Quantification on Orbitrap-Type Mass Spectrometers
Mikhail M. Savitski et al.
ANALYTICAL CHEMISTRY (2011)
PI3Kγ Mediates Kaposi's Sarcoma-Associated Herpesvirus vGPCR-Induced Sarcomagenesis
Daniel Martin et al.
CANCER CELL (2011)
Receptor Tyrosine Kinases and TLR/IL1 Rs Unexpectedly Activate Myeloid Cell PI3Kγ, A Single Convergent Point Promoting Tumor Inflammation and Progression
Michael C. Schmid et al.
CANCER CELL (2011)
PI3Kδ drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation
Sarah Haylock-Jacobs et al.
JOURNAL OF AUTOIMMUNITY (2011)
Chemoproteomics-based kinome profiling and target deconvolution of clinical multi-kinase inhibitors in primary chronic lymphocytic leukemia cells
U. Kruse et al.
LEUKEMIA (2011)
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
Marcus Bantscheff et al.
NATURE BIOTECHNOLOGY (2011)
A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations
Luis I. Toledo et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Blockade of class IB phosphoinositide-3 kinase ameliorates obesity-induced inflammation and insulin resistance
Naoki Kobayashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
PI3Kγ within a nonhematopoietic cell type negatively regulates diet-induced thermogenesis and promotes obesity and insulin resistance
Barbara Becattini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Evaluation of Data Analysis Strategies for Improved Mass Spectrometry-Based Phosphoproteomics
Mikhail M. Savitski et al.
ANALYTICAL CHEMISTRY (2010)
LY2439821, a Humanized Anti-Interleukin-17 Monoclonal Antibody, in the Treatment of Patients With Rheumatoid Arthritis A Phase I Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study
M. C. Genovese et al.
ARTHRITIS AND RHEUMATISM (2010)
PI3K inhibition in inflammation: Toward tailored therapies for specific diseases
Alessandra Ghigo et al.
BIOESSAYS (2010)
Discovery of Dual Inhibitors of the Immune Cell PI3Ks p110δ and p110γ: a Prototype for New Anti-inflammatory Drugs
Olusegun Williams et al.
CHEMISTRY & BIOLOGY (2010)
Application of Chemoproteomics to Drug Discovery: Identification of a Clinical Candidate Targeting Hsp90
Patrick Fadden et al.
CHEMISTRY & BIOLOGY (2010)
Targeted Data Acquisition for Improved Reproducibility and Robustness of Proteomic Mass Spectrometry Assays
Mikhail M. Savitski et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2010)
The emerging mechanisms of isoform-specific PI3K signalling
Bart Vanhaesebroeck et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Proinflammatory T helper type 17 cells are effective B-cell helpers
Meike Mitsdoerffer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Chemical target and pathway toxicity mechanisms defined in primary human cell systems
Ellen L. Berg et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2010)
Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Blockade Is an Effective Radiosensitizing Strategy for the Treatment of Non-Small Cell Lung Cancer Harboring K-RAS Mutations
Georgia Konstantinidou et al.
CANCER RESEARCH (2009)
Infliximab treatment reduces the serum levels of interleukin-23 in patients with rheumatoid arthritis
Yasunori Kageyama et al.
MODERN RHEUMATOLOGY (2009)
Proteomics strategy for quantitative protein interaction profiling in cell extracts
Kirti Sharma et al.
NATURE METHODS (2009)
Specific apoptosis induction by the dual PI3K/mTor inhibitor NVP-BEZ235 in HER2 amplified and PIK3CA mutant breast cancer cells
Saskia M. Brachmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
PI3Kγ Adaptor Subunits Define Coupling to Degranulation and Cell Motility by Distinct PtdIns(3,4,5)P3 Pools in Mast Cells
Thomas Bohnacker et al.
SCIENCE SIGNALING (2009)
Genetic and pharmacological targeting of phosphoinositide 3-kinase-γ reduces atherosclerosis and favors plaque stability by modulating inflammatory processes
Anne Fougerat et al.
CIRCULATION (2008)
A selective PIKfyve inhibitor blocks PtdIns(3,5) P2 production and disrupts endomembrane transport and retroviral budding
Harold B. J. Jefferies et al.
EMBO REPORTS (2008)
Phosphoinositide 3-Kinases γ and δ, Linkers of Coordinate C5a Receptor-Fcγ Receptor Activation and Immune Complex-induced Inflammation
Stephanie Konrad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
Sauveur-Michel Maira et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Phosphoinositide 3-Kinase p110β Activity: Key Role in Metabolism and Mammary Gland Cancer but Not Development
Elisa Ciraolo et al.
SCIENCE SIGNALING (2008)
Inactivation of PI3Kγ and PI3Kδ distorts T-cell development and causes multiple organ inflammation
Hong Ji et al.
BLOOD (2007)
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Marcus Bantscheff et al.
NATURE BIOTECHNOLOGY (2007)
IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways
Liang Zhou et al.
NATURE IMMUNOLOGY (2007)
PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?
Christian Rommel et al.
NATURE REVIEWS IMMUNOLOGY (2007)
PI3Kγ inhibition:: towards an 'aspirin of the 21st century'?
Thomas Rueckle et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Signalling through class I PI3Ks in mammalian cells
P. T. Hawkins et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
A pharmacological map of the PI3-K family defines a role for p110α in insulin signaling
Zachary A. Knight et al.
CELL (2006)
Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation
LC Foukas et al.
NATURE (2006)
Key role of the p110δ isoforrn of PI3K in B-cell antigen and IL-4 receptor signaling:: comparative analysis of genetic and pharmacologic interference with p110δ function in B cells
A Bilancio et al.
BLOOD (2006)
A pharmacological map of the PI3-K family defines a role for p110 alpha in insulin signaling
Zachary A. Knight et al.
CELL (2006)
Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis
M Camps et al.
NATURE MEDICINE (2005)
Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils
AM Condliffe et al.
BLOOD (2005)
Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3Kγ
C Vecchione et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion
E Lubberts et al.
ARTHRITIS AND RHEUMATISM (2004)
PI3Kγ modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects
E Patrucco et al.
CELL (2004)
Requirement for PI 3-kinase γ in macrophage migration to MCP-1 and CSF-1
GE Jones et al.
EXPERIMENTAL CELL RESEARCH (2003)
Discovery of novel targets of quinoline drugs in the human purine binding proteome
PR Graves et al.
MOLECULAR PHARMACOLOGY (2002)
Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation
E Hirsch et al.
SCIENCE (2000)
Share Paper
